Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmacosmos Holding A/S
A/S
Active
CVR 69720919
Rørvangsvej 30, 4300
Holbæk
Activities of holding companies
·
NACE 6421
Est. 1965 · 60 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Pharmacosmos Holding A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
4.2B
3.1B
2.1B
1.0B
0B
2021: 0.0B
0.0B
2021
2022: 0.0B (+700% vs 2021)
0.0B
+700%
2022
2023: 0.0B (+29% vs 2022)
0.0B
+29%
2023
2024: 0.0B (+29% vs 2023)
0.0B
+29%
2024
2025: 3.4B (+8305% vs 2024)
3.4B
+8305%
2025
EBITDA
DKK millions
3.4B
2.4B
1.3B
0.2B
-0.8B
2021: -0.0B
-0.0B
2021
2022: 0B (+100% vs 2021)
0B
+100%
2022
2023: 0.0B
0.0B
2023
2024: 0.0B (+38% vs 2023)
0.0B
+38%
2024
2025: 2.6B (+23455% vs 2024)
2.6B
+23455%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
3.362.000
40.373
30.638
23.552
2.684
Staff expenses
-0
-0
-16.067
-0
-0
EBITDA
2.591.000
11.200
8.093
297
-4.734
Depreciation & amort.
-264.000
-0
-0
-0
-0
EBIT
2.327.000
11.200
8.093
297
-4.734
Net financials
1.434.000
801.884
122.603
184.388
-122.847
Profit before tax
2.129.000
813.084
130.696
184.685
-127.581
Tax
477.000
4.401
2.052
249
-3.568
Net profit
1.652.000
808.683
128.644
184.436
-124.013
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
5.696.000
1.862.557
1.052.477
983.871
792.364
Equity
2.273.000
1.831.595
1.031.422
969.925
790.862
Long-term debt
2.123.000
0
0
0
0
Short-term debt
1.300.000
30.962
21.055
13.946
1.502
Total debt
3.423.000
30.962
21.055
13.946
1.502
Financial ratios
5-year trend
EBITDA margin
77,1 %
This company
15,8 %
Market median
This company
Market median
388% above market
2021
2025
Equity ratio
39,9 %
This company
38,2 %
Market median
This company
Market median
4% above market
2021
2025
Return on equity
72,7 %
This company
18,4 %
Market median
This company
Market median
295% above market
2021
2025
Net profit margin
49,1 %
This company
8,1 %
Market median
This company
Market median
506% above market
2021
2025
Asset turnover
0,59×
This company
1,12×
Market median
This company
Market median
47% below market
2021
2025
Debt / equity
1,51×
This company
0,62×
Market median
This company
Market median
144% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
View
PDF
More on Pharmacosmos Holding A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
